GlassScriptPhysician profile
Emilie Potter
NPI 1114797370
$1,032.91
in general payments reported to CMS, 2019-2025
8 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $701 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.92 |
| Education | $148.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $243.92 | 2024-2025 | Epkinly |
| Janssen Biotech, INC. | $214.21 | 2024 | Carvykti, Tecvayli, Darzalex |
| Astrazeneca Pharmaceuticals LP | $210.78 | 2024 | Enhertu |
| Janssen Scientific Affairs, LLC | $134.00 | 2024-2025 | Carvykti, Tecvayli, Talvey |
| Novartis Pharmaceuticals Corporation | $74.96 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $70.40 | 2024 | Opdivo |
| Incyte Corporation | $49.99 | 2025 | |
| Glaxosmithkline, LLC. | $34.65 | 2024 | Jemperli, Zejula |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilie Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.